Sign In
Last checked at 
22 Nov 2011 15:49
ο»Ώ
For immediate release | 22 November 2011 |
Β
Β
Β
Futura Medical plc
("Futura" or "the Company")
Β
Block Listing Update
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that in the six months from the block admission application to AIM on 25 May 2011 for a total of 2,335,000 ordinary shares of 0.2p each in the Company the following changes have taken place:
Futura Medical plc Option Plan | No of Shares in Block Admission | Options Exercised in Period | Block Listing Carried Forward |
Unapproved Share Option Scheme | 814,424 | (130,269) | 684,155 |
EMI Share Option Scheme | 1,520,576 | (49,731) | 1,470,845 |
2,335,000 | (180,000) | 2,155,000 |
Β
For any further information please contact:
Β
Futura Medical plc | |
James Barder, Chief Executive | Tel: +44 (0) 1483 685 670 |
mail to: james.barder@futuramedical.com | www.futuramedical.com |
Nomura Code Securities Limited | |
Phil Walker / Giles Balleny | Tel:+44 (0)20 7776 1200 |
For media enquiries please contact: | |
Buchanan | |
Mark Court / Jessica Fontaine | Tel: +44 (0) 20 7466 5000 |
Β
Β
Notes to Editors
Β
Futura Medical plc
Β
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Β
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
Β
www.futuramedical.com
Β
Β
Β
Follow the stocks
